CAS 381186-64-7

RBC6

CAS : 381186-64-7

RBC6 is a compound with antiviral and anticancer activities. It has been shown to be effective against human immunodeficiency virus type-1 (HIV-1), human serum, and cancer cells. RBC6 is a non-toxic molecule that can be delivered orally or intravenously. The antiviral activity of RBC6 is due to its ability to inhibit viral replication by binding to the viral nucleic acid and preventing it from being synthesized into RNA. This antiviral effect may also be due to the inhibition of fatty acid synthesis in the virus, which prevents the production of new virus particles. RBC6 has also been shown to have anticancer properties, as it inhibits cell proliferation by blocking DNA synthesis at the G2/M phase transition.

Formule : C₁₆H₁₄Cl₂N₄O₂

Degré de pureté : Min. 95%

Masse moléculaire : 365.2 g/mol

Ref: 3D-GQA18664

RBC6

CAS : 381186-64-7

RBC6 is an inhibitor of the binding of Ral to its effector RALBP1.

Formule : C₁₆H₁₄Cl₂N₄O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 365.21

Ref: TM-T24707